Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIOW) Share-based Compensation (2023 - 2025)

Historic Share-based Compensation for Cardio Diagnostics Holdings (CDIOW) over the last 3 years, with Q3 2025 value amounting to $24762.0.

  • Cardio Diagnostics Holdings' Share-based Compensation rose 947.92% to $24762.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $108567.0, marking a year-over-year decrease of 9587.32%. This contributed to the annual value of $2.6 million for FY2024, which is 10255.0% up from last year.
  • According to the latest figures from Q3 2025, Cardio Diagnostics Holdings' Share-based Compensation is $24762.0, which was up 947.92% from $30778.0 recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' Share-based Compensation ranged from a high of $2.5 million in Q1 2024 and a low of $4000.0 during Q1 2023
  • In the last 3 years, Cardio Diagnostics Holdings' Share-based Compensation had a median value of $30612.0 in 2025 and averaged $359690.3.
  • Its Share-based Compensation has fluctuated over the past 5 years, first surged by 6288510.0% in 2024, then crashed by 9878.5% in 2025.
  • Quarter analysis of 3 years shows Cardio Diagnostics Holdings' Share-based Compensation stood at $62000.0 in 2023, then crashed by 63.85% to $22415.0 in 2024, then increased by 10.47% to $24762.0 in 2025.
  • Its Share-based Compensation stands at $24762.0 for Q3 2025, versus $30778.0 for Q2 2025 and $30612.0 for Q1 2025.